Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2029 | |
|
|
|
| % | |
|
Global Oral Drug Delivery Market, By Type (Controlled Release, Orodispersible Tablets, Taste Making), Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications), End User (Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
The oral drug delivery market is expected to witness market growth at a rate of 7.60% in the forecast period of 2022 to 2029. Data Bridge Market Research report on oral drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the healthcare sector globally is escalating the growth of oral drug delivery market.
Drug delivery systems refer to the type of systems that are employed to deliver therapeutic agents in a controlled manner. Drugs are delivered through various routes such as nasal, intravenous or oral. These drugs can be absorbed through the skin too. Oral drug delivery systems offer tablets and films.
The rise in the geriatric population across the globe acts as one of the major factors driving the growth of oral drug delivery market. The increase in demand for self-administration and home care facilities among people, and surge in demand for investments in pharmaceutical research and development accelerate the market growth. The growth in the biologics market and increase in demand for biosimilar and biologics further influence the market. Additionally, growth in awareness, surge in aging population, improvements in the medical industry and prevalence of chronic diseases positively affects the oral drug delivery market. Furthermore, technological advancements and new product launches extend profitable opportunity to the market players in the forecast period of 2022 to 2029.
On the other hand, risk of needlestick injuries is expected to obstruct the market growth. Pricing pressure is projected to challenge the oral drug delivery market in the forecast period of 2022-2029.
This oral drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on oral drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The oral drug delivery market is segmented on the basis of type, application and end- users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
The oral drug delivery market is analyzed and market size insights and trends are provided by country, type, application and end- users as referenced above.
The countries covered in the oral drug delivery market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the oral drug delivery market because of the increase in prevalence of chronic diseases, such as cancer, respiratory allergies, and diabetes within the region. Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the research and development activities in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The oral drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oral drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oral drug delivery market. The data is available for historic period 2010-2020.
The oral drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to oral drug delivery market.
Some of the major players operating in the oral drug delivery market report are AbbVie Inc., EnteraBio Ltd., Catalent, Inc., Novartis AG, Biocon., Novo Nordisk A/S., F. Hoffmann-La Roche Ltd, Bayer AG, 3M, Evonik Industries, Skyepharma Production SAS, Chimerix., SAMYANG BIOPHARMACEUTICAL CORPORATION, Oramed, Emisphere Technologies, Enteris BioPharma, AdhexPharma., and ARx, LLC., among others.
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.